BR112015012482A2 - ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos - Google Patents
ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicosInfo
- Publication number
- BR112015012482A2 BR112015012482A2 BR112015012482A BR112015012482A BR112015012482A2 BR 112015012482 A2 BR112015012482 A2 BR 112015012482A2 BR 112015012482 A BR112015012482 A BR 112015012482A BR 112015012482 A BR112015012482 A BR 112015012482A BR 112015012482 A2 BR112015012482 A2 BR 112015012482A2
- Authority
- BR
- Brazil
- Prior art keywords
- neutralizing
- therapy
- assays
- present
- biological
- Prior art date
Links
- 230000003472 neutralizing effect Effects 0.000 title abstract 7
- 238000003556 assay Methods 0.000 title abstract 3
- 238000001815 biotherapy Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 4
- 238000002560 therapeutic procedure Methods 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 3
- 238000012544 monitoring process Methods 0.000 abstract 2
- 239000003124 biologic agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000009260 cross reactivity Effects 0.000 abstract 1
- 238000005457 optimization Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261732251P | 2012-11-30 | 2012-11-30 | |
| US13/802,117 US20130266963A1 (en) | 2011-07-06 | 2013-03-13 | Assay for detecting neutralizing autoantibodies to biologic therapy |
| PCT/IB2013/060458 WO2014083520A2 (en) | 2012-11-30 | 2013-11-27 | Assays for detecting neutralizing autoantibodies to biologic therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015012482A2 true BR112015012482A2 (pt) | 2017-07-11 |
Family
ID=50828561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015012482A BR112015012482A2 (pt) | 2012-11-30 | 2013-11-21 | ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2926136A2 (https=) |
| JP (1) | JP2016502091A (https=) |
| KR (1) | KR20150088890A (https=) |
| CN (1) | CN105074461A (https=) |
| AU (1) | AU2013350817A1 (https=) |
| BR (1) | BR112015012482A2 (https=) |
| CA (1) | CA2892766A1 (https=) |
| HK (1) | HK1215969A1 (https=) |
| IL (1) | IL238995A0 (https=) |
| MX (1) | MX2015006852A (https=) |
| RU (1) | RU2015125739A (https=) |
| SG (2) | SG11201504097PA (https=) |
| WO (1) | WO2014083520A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ621655A (en) | 2009-10-26 | 2015-08-28 | Nestec Sa | Assays for the detection of anti-tnf drugs and autoantibodies |
| NZ609363A (en) | 2010-10-18 | 2015-04-24 | Nestec Sa | Methods for determining anti-drug antibody isotypes |
| MX343324B (es) | 2011-07-06 | 2016-11-01 | Nestec Sa | Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha. |
| WO2016088104A2 (en) | 2014-12-05 | 2016-06-09 | Nestec S.A. | Indirect homogeneous mobility shift assays for the detection of biologics in patient samples |
| WO2016110595A1 (en) | 2015-01-09 | 2016-07-14 | Atonomics A/S | A UNIVERSAL ASSAY FOR DETERMINING THE QUANTITY OF TNFα INHIBITORY DRUGS AND THEIR CORRESPONDING ANTI-DRUG-ANTIBODIES |
| EP3482199A1 (en) * | 2016-07-08 | 2019-05-15 | Atonomics A/S | A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples |
| EP3602056A1 (en) | 2017-03-31 | 2020-02-05 | Ablynx N.V. | Improved immunogenicity assays |
| JP7570421B2 (ja) * | 2020-01-02 | 2024-10-21 | エフ． ホフマン－ラ ロシュ アーゲー | Ａｄａ応答特定アッセイ |
| CN111024958B (zh) * | 2020-03-11 | 2020-06-23 | 同昕生物技术（北京）有限公司 | 用于检测单抗药物和抗单抗药物抗体的试剂及其应用 |
| CN112730846B (zh) * | 2020-12-18 | 2023-12-15 | 安渡生物医药(杭州)有限公司 | 一种用于小鼠血样检测免疫复合物的方法 |
| CN114047343B (zh) * | 2022-01-13 | 2022-05-31 | 美迪西普亚医药科技(上海)有限公司 | 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用 |
| CN117871856A (zh) * | 2023-12-15 | 2024-04-12 | 首都医科大学附属北京地坛医院 | 可溶性因子在无症状神经梅毒检测中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ621655A (en) * | 2009-10-26 | 2015-08-28 | Nestec Sa | Assays for the detection of anti-tnf drugs and autoantibodies |
| JP2013527444A (ja) * | 2010-04-29 | 2013-06-27 | テラディアグ・ソシエテ・アノニム | 抗体を検出するための方法 |
| NZ609363A (en) * | 2010-10-18 | 2015-04-24 | Nestec Sa | Methods for determining anti-drug antibody isotypes |
| DK2676137T3 (en) * | 2011-02-17 | 2015-01-19 | Nestec Sa | TESTS TO DETECT AUTO ANTIBODIES FOR ANTI-TNF PHARMACEUTICALS |
| MX343324B (es) * | 2011-07-06 | 2016-11-01 | Nestec Sa | Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha. |
-
2013
- 2013-11-21 BR BR112015012482A patent/BR112015012482A2/pt not_active IP Right Cessation
- 2013-11-27 AU AU2013350817A patent/AU2013350817A1/en not_active Abandoned
- 2013-11-27 WO PCT/IB2013/060458 patent/WO2014083520A2/en not_active Ceased
- 2013-11-27 SG SG11201504097PA patent/SG11201504097PA/en unknown
- 2013-11-27 MX MX2015006852A patent/MX2015006852A/es unknown
- 2013-11-27 CN CN201380071748.4A patent/CN105074461A/zh active Pending
- 2013-11-27 RU RU2015125739A patent/RU2015125739A/ru not_active Application Discontinuation
- 2013-11-27 CA CA2892766A patent/CA2892766A1/en not_active Abandoned
- 2013-11-27 HK HK16103834.6A patent/HK1215969A1/zh unknown
- 2013-11-27 JP JP2015544592A patent/JP2016502091A/ja active Pending
- 2013-11-27 SG SG10201703210XA patent/SG10201703210XA/en unknown
- 2013-11-27 EP EP13820955.6A patent/EP2926136A2/en not_active Withdrawn
- 2013-11-27 KR KR1020157017311A patent/KR20150088890A/ko not_active Withdrawn
-
2015
- 2015-05-25 IL IL238995A patent/IL238995A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014083520A2 (en) | 2014-06-05 |
| RU2015125739A (ru) | 2017-01-13 |
| IL238995A0 (en) | 2015-07-30 |
| CA2892766A1 (en) | 2014-06-05 |
| EP2926136A2 (en) | 2015-10-07 |
| WO2014083520A3 (en) | 2014-07-31 |
| HK1215969A1 (zh) | 2016-09-30 |
| AU2013350817A1 (en) | 2015-06-11 |
| KR20150088890A (ko) | 2015-08-03 |
| CN105074461A (zh) | 2015-11-18 |
| SG11201504097PA (en) | 2015-06-29 |
| JP2016502091A (ja) | 2016-01-21 |
| MX2015006852A (es) | 2015-09-16 |
| SG10201703210XA (en) | 2017-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015012482A2 (pt) | ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos | |
| BR112015017403A2 (pt) | biomarcadores de terapia de combinação de anti-tnf e anti-il17 para doença inflamatória | |
| MX343327B (es) | Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. | |
| NZ609493A (en) | Diagnosis and treatments relating to th2 inhibition | |
| MX2014006158A (es) | Metodos para el tratamiento de artritis psoriasica (psa) utilizando antagonistas de il-17 y alelos con respuesta o sin respuesta a la psa. | |
| BR112015012644A2 (pt) | método para determinar a necessidade de um paciente com câncer, método de tratamento do câncer, composição farmacêutica, uso de um ácido nucleico ou anticorpo e kit; | |
| BR112014031365A2 (pt) | métodos de detectar doenças ou condições | |
| AR098155A1 (es) | Métodos para diagnosticar y tratar trastornos eosinofílicos | |
| MX390772B (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
| MX374652B (es) | Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco. | |
| WO2011154139A3 (en) | Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment | |
| WO2012118750A3 (en) | Biological markers and methods for predicting response to b-cell antagonists | |
| BR112013006683A2 (pt) | diagnóstico de câncer de mama | |
| ATE531725T1 (de) | Verfahren zur vorhersage ob nsclc-patienten auf eine behandlung mit einem egfr-tk-hemmer ansprechen | |
| BR112013027867A2 (pt) | "método de detectar o nível de um anticorpo anti-ip10 em amostra, anticorpo monoclonal isolado ou porção de ligação de antígeno do mesmo, linhagem de célula de hibridoma e kit" | |
| EP2569635A4 (en) | METHOD FOR DIAGNOSIS AND / OR TREATMENT OF ENZEPHALITIS OR EPILEPSY | |
| BR112015013771A2 (pt) | biomarcador preditivo de resposta ao tratamento de ativador do receptor alfa 7 nicotínico de acetilcolina | |
| EP3371607A4 (en) | DEVICE AND SYSTEM FOR BIOFLUID TESTING AND / OR TESTING | |
| BR112014011758A2 (pt) | composição farmacêutica, proteína de fusão, polinucleotídeo, vetor, célula isolada, métodos para produzir uma proteína de fusão, para tratar ou previnir uma doença ou condição, para diagnosticar a suscetibilidade de um indivíduo a desenvolver uma doença ou condição, para determinar uma adequabilidade do indivíduo para ingressar em um experimento de classificação dedroga, e para identificar um agente, uso de uma combinação, e, combinação. | |
| EP2845910A4 (en) | PROBE OR PROBE TO EVALUATE THE INFLUENCE OF ULTRAVIOLET RADIATION ON SKIN AND NUCLEIC ACID MICRO ARRAYS | |
| EP2757153A4 (en) | METHOD OF ASSESSING THE PRESIDITION OF MYELODYSPLASTIC SYNDROME OR MYELOIC TUMOR, POLYPEPTIDE AND ANTIBODIES THEREFOR, AND CANDIDATE SCREENING METHOD FOR THERAPEUTIC OR PROPHYLACTIC ACTIVE SUBSTANCE | |
| BR112012028010A2 (pt) | anticorpo isolado, célula, ácido nucleíco isolado, método de identificação de um primeiro anticorpo que se liga a um epítopo antigênico tat425 ligado or um anticorpo, métodos de inibir o crescimento de uma célula, de tratamento terapêutico de determinação da presença de uma proteína de tat425 e de diagnóstico da presença de um tumor em um mamífero | |
| BR112014027413A2 (pt) | biomarcadores para terapia com inibidor de iap | |
| EA201490548A1 (ru) | Молекулярно-генетический подход для лечения и диагностики алкогольной и наркотической зависимости | |
| BR112013020241A2 (pt) | métodos de análise de placa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |